药明康德:预计2025年全年净利润同比增长约102.6%至191.5亿元
Cai Jing Wang·2026-01-12 11:51

Core Viewpoint - WuXi AppTec is expected to achieve significant revenue and profit growth in 2025, driven by its core business operations and strategic asset sales [1] Financial Performance - The company anticipates total revenue of approximately RMB 45.46 billion for 2025, representing a year-on-year increase of about 15.8% [1] - Revenue from continuing operations is projected to grow by approximately 21.4% year-on-year [1] - The expected net profit attributable to shareholders is around RMB 19.15 billion, reflecting a substantial year-on-year growth of approximately 102.6% [1] - The basic earnings per share for 2025 is estimated to be about RMB 6.70, which indicates a year-on-year increase of approximately 104.3% [1]

WuXi AppTec-药明康德:预计2025年全年净利润同比增长约102.6%至191.5亿元 - Reportify